中药银杏制剂的心血管药理效应:机制与展望

被引:26
作者
郭明 [1 ,2 ]
刘玥 [1 ,2 ]
许琳 [3 ]
付长庚 [1 ,2 ]
陈可冀 [1 ,2 ]
机构
[1] 中国中医科学院西苑医院心血管病中心
[2] 中国中医科学院心血管病研究所
[3] 卫生部中日友好医院
关键词
银杏; 中药; 心血管疾病; 机制; 展望;
D O I
暂无
中图分类号
R285 [中药药理学];
学科分类号
1008 ;
摘要
银杏是传统的活血化瘀中药,银杏制剂是现代科技开发的植物药中最为成功的案例之一.目前研究较多的银杏制剂是银杏酮酯,其主要活性成分为银杏黄酮、银杏内酯等,具有较为广泛的心血管药理效应,对多种心血管疾病具有较好的预防和治疗效果.本文对中药银杏制剂的主要活性成分、心血管药理效应及其机制、研究展望做一述评.
引用
收藏
页码:543 / 550
页数:8
相关论文
共 37 条
[1]  
银杏酮酯滴丸用于治疗冠心病心绞痛(心血瘀阻证)的临床观察研究.[D].梁丽喆.辽宁中医药大学.2012, 06
[2]   Ginkgo biloba extract reducing myocardium cells apoptosis by regulating apoptotic related proteins expression in myocardium tissues [J].
Qiao, Zeng Yong ;
Huang, Jian Hua ;
Ma, Jiang Wei ;
Xu, Ya Wei ;
Xie, Jun ;
Liu, Hua Jin ;
Xiong, San Jun ;
Ge, Guang Hao .
MOLECULAR BIOLOGY REPORTS, 2014, 41 (01) :347-353
[3]  
Ginkgo biloba extract (EGb 761) normalizes hypertension in 2K; 1C hypertensive rats: Role of antioxidant mechanisms; ACE inhibiting activity and improvement of endothelial dysfunction.[J].Suzan M. Mansour;Ashraf K. Bahgat;Aiman S. El-Khatib;Mohamed T. Khayyal.Phytomedicine.2011, 8
[4]  
Nrf-2 mediated heme oxygenase-1 expression; an antioxidant-independent mechanism; contributes to anti-atherogenesis and vascular protective effects of Ginkgo biloba extract.[J].Jia-Shiong Chen;Po-Hsun Huang;Chao-Hung Wang;Feng-Yen Lin;Hsiao-Ya Tsai;Tao-Cheng Wu;Shing-Jong Lin;Jaw-Wen Chen.Atherosclerosis.2010, 2
[5]  
Targeting the cell cycle machinery for the treatment of cardiovascular disease.[J].Katrina A.Bicknell;Elizabeth L.Surry;GavinBrooks.Journal of Pharmacy and Pharmacology.2010, 5
[6]   Chemical analysis and quality control of Ginkgo biloba leaves, extracts, and phytopharmaceuticals [J].
van Beek, Teris A. ;
Montoro, Paola .
JOURNAL OF CHROMATOGRAPHY A, 2009, 1216 (11) :2002-2032
[7]   Reduction of atherosclerotic nanoplaque formation and size by Ginkgo biloba (EGb 761) in cardiovascular high-risk patients [J].
Rodriguez, M. ;
Ringstad, L. ;
Schaefer, P. ;
Just, S. ;
Hofer, H. W. ;
Malmsten, M. ;
Siegel, G. .
ATHEROSCLEROSIS, 2007, 192 (02) :438-444
[8]   Terpene trilactones from Gingko biloba:: From ancient times to the 21st century [J].
Nakanishi, K .
BIOORGANIC & MEDICINAL CHEMISTRY, 2005, 13 (17) :4987-5000
[9]  
效阈浓度下中药多成分的生物效应模式.[D].伊丽萦.北京中医药大学.2005, 05
[10]  
全球银杏叶制剂专利概况.[J].程心旻;雷海民;刘伟;.中国中药杂志.2013, 17